Organizing stroke systems in the field for patients with suspected large vessel occlusion acute stroke

References

• National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1587.
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329.
   PubMed Web of Science ®Google Scholar
• Saver JL. Time is brain–quantified. Stroke. 2006;37(1):263–266.
   PubMed Web of Science ®Google Scholar
• Reeves MJ, Parker C, Fonarow GC, et al. Development of stroke performance measures: definitions, methods, and current measures. Stroke. 2010;41(7):1573–1578.
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311(16):1632–1640.
   PubMed Web of Science ®Google Scholar
• Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893–903.
   PubMed Web of Science ®Google Scholar
• Ciccone A, Valvassori L. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(25):2433–2434.
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914–923.
   PubMed Web of Science ®Google Scholar
• Menon BK, Almekhlafi MA, Pereira VM, et al. Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR thrombectomy for acute revascularization study. Stroke. 2014;45(7):2024–2029.
   PubMed Web of Science ®Google Scholar
• Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241–1249.
   PubMed Web of Science ®Google Scholar
• Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Derdeyn CP, Biller J, et al. 2015 American heart association/American stroke association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2015;46(10):3020–3035.
   PubMed Web of Science ®Google Scholar
• Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708–718.
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.
   PubMed Web of Science ®Google Scholar
• Lopez-Cancio E, Ribo M, Cardona P, et al. Telestroke in Catalonia: increasing thrombolysis rate and avoiding interhospital transfers. Cerebrovasc Dis. 2018;46(1–2):66–71.
   PubMed Web of Science ®Google Scholar
• Menon BK, Sajobi TT, Zhang Y, et al. Analysis of workflow and time to treatment on thrombectomy outcome in the endovascular treatment for small core and proximal occlusion ischemic stroke (ESCAPE) randomized, controlled trial. Circulation. 2016;133(23):2279–2286.
   PubMed Web of Science ®Google Scholar
• Smith EE, Kent DM, Bulsara KR, et al. Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49(3):e111–e122.
   PubMed Web of Science ®Google Scholar
• Uchida K, Yoshimura S, Hiyama N, et al. Clinical prediction rules to classify types of stroke at prehospital stage: Japan Urgent Stroke Triage (JUST) score. Stroke. 2018;49(8):1820–1827.
   PubMed Web of Science ®Google Scholar
• Zhao H, Pesavento L, Rodrigues E, et al. Abstract TMP68: ACT-FAST algorithm: paramedic validation of A 3-step algorithmic approach to large vessel occlusion identification. Stroke. 2018;49(Suppl_1):ATMP68–ATMP68.
   Google Scholar
• Zhao H, Pesavento L, Rodrigues E, et al. Abstract TMP68: ACT-FAST algorithm: paramedic validation of A 3-step algorithmic approach to large vessel occlusion identification. (2018):ATMP68-ATMP68.
   Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;49(3):e46–e110.
   PubMed Web of Science ®Google Scholar
• McTaggart RA, Yaghi S, Cutting SM, et al. Association of a primary stroke center protocol for suspected stroke by large-vessel occlusion with efficiency of care and patient outcomes. JAMA Neurol. 2017;74(7):793–800.
   PubMed Web of Science ®Google Scholar
• Demchuk AM, Menon BK, Goyal M. Comparing vessel imaging: noncontrast computed tomography/computed tomographic angiography should be the new minimum standard in acute disabling stroke. Stroke. 2016;47(1):273–281.
   PubMed Web of Science ®Google Scholar
• Abilleira S, Ribera A, Cardona P, et al. Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different. Stroke. 2017;48(2):375–378.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Schellinger PD, et al. Successful recanalization with intravenous thrombolysis preceding mechanical thrombectomy in large vessel occlusions: a systematic review and meta-analysis. Stroke. 2018;49(Suppl_1):A83–A83.
   Web of Science ®Google Scholar
• Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA. 2015;314(17):1832–1843.
   PubMed Web of Science ®Google Scholar
• Weber R, Nordmeyer H, Hadisurya J, et al. Comparison of outcome and interventional complication rate in patients with acute stroke treated with mechanical thrombectomy with and without bridging thrombolysis. J Neurointerv Surg. 2017;9(3):229–233.
   PubMed Web of Science ®Google Scholar
• Huang X, MacIsaac R, Thompson JL, et al. Tenecteplase versus alteplase in stroke thrombolysis: an individual patient data meta-analysis of randomized controlled trials. Int J Stroke. 2016;11(5):534–543.
   PubMed Web of Science ®Google Scholar
• Huang X, Cheripelli BK, Lloyd SM, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015;14(4):368–376.
   PubMed Web of Science ®Google Scholar
• Campbell BC, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study. Int J Stroke. 2018;13(3):328–334.
   PubMed Web of Science ®Google Scholar
• Coutts SB, Dubuc V, Mandzia J, et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion. Stroke. 2015;46(3):769–774.
   PubMed Web of Science ®Google Scholar
• Logallo N, Kvistad CE, Nacu A, et al. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol. 2014;14:106.
   PubMed Web of Science ®Google Scholar
• Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366(12):1099–1107.
   PubMed Web of Science ®Google Scholar
• Haley EC Jr., Thompson JL, Grotta JC, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke. 2010;41(4):707–711.
   PubMed Web of Science ®Google Scholar
• Haley EC Jr., Lyden PD, Johnston KC, et al. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke. 2005;36(3):607–612.
   PubMed Web of Science ®Google Scholar
• Milne MS, Holodinsky JK, Hill MD, et al. Drip ‘n ship versus mothership for endovascular treatment: modeling the best transportation options for optimal outcomes. Stroke. 2017;48(3):791–794.
   PubMed Web of Science ®Google Scholar
• Holodinsky JK, Williamson TS, Kamal N, et al. Ship versus direct to comprehensive stroke center: conditional probability modeling. Stroke. 2017;48(1):233–238.
   PubMed Web of Science ®Google Scholar
• Holodinsky JK, Williamson TS, Demchuk AM, et al. Modeling stroke patient transport for all patients with suspected large-vessel occlusion. JAMA Neurol. Published online September 4, 2018. doi:10.1001/jamaneurol.2018.2424
   PubMedGoogle Scholar
• [cited 2018 Oct 24]. Available from: www.destinehealth.com
   Google Scholar
• Kamal N, Wiggam MI, Holodinsky JK, et al. Geographic modeling of best transport options for treatment of acute ischemic stroke patients: applied to policy decision making in the USA and Northern Ireland. IISE Trans Healthc Syst Eng. 2018;1–20.
   Google Scholar
• Persson M, Fhager A, Trefna HD, et al. Microwave-based stroke diagnosis making global prehospital thrombolytic treatment possible. IEEE Trans Biomed Eng. 2014;61(11):2806–2817.
   PubMed Web of Science ®Google Scholar
• Luger S, Witsch J, Dietz A, et al. Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin Chem. 2017;63(1):377–385.
   Web of Science ®Google Scholar
• Bustamante A, López-Cancio E, Pich S, et al. Blood biomarkers for the early diagnosis of stroke: the stroke-chip study. Stroke. 2017;48(9):2419–2425.
   PubMed Web of Science ®Google Scholar
• Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol. 2012;11(5):397–404.
   PubMed Web of Science ®Google Scholar
• Goyal M, Menon BK, Wilson AT, et al. Primary to comprehensive stroke center transfers: appropriateness, not futility. Int J Stroke. 2018 1747493018764072
   Web of Science ®Google Scholar
• Holodinsky JK, Kamal N, Zerna C, et al. Abstract TP275: modelling the impact of mobile stroke unit dispatcher accuracy on patient outcomes. Am Heart Assoc. 2018:ATP275–ATP275.
   Google Scholar
• Kamal N, Jeerakathil T, Smith E, et al. MP28: reducing door-to-needle times across Alberta to 36 minutes. Cjem. 2018;20(S1):S50–S51.
   Google Scholar
• Kamal N, Benavente O, Boyle K, et al. Good is not good enough: the benchmark stroke door-to-needle time should be 30 minutes. Can J Neurol Sci. 2014;41(6):694–696.
   PubMed Web of Science ®Google Scholar